CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study.

MLA

Zheng, Yuting, et al. “CT-Based Delta-Radiomics for Predicting Pathological Response to Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Multicenter Study.” BMC Medical Imaging, vol. 24, no. 1, Dec. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12880-024-01503-1.

APA

Zheng, Y., Mei, P., Wang, M., Luo, Q., Li, H., Ding, C., Zhang, K., Chen, L., Gu, J., Li, Y., Guo, T., Zhang, C., Yao, W., Wei, L., Liao, Y., Han, X., & Shi, H. (2024). CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study. BMC Medical Imaging, 24(1), 1–12. https://doi.org/10.1186/s12880-024-01503-1

Chicago

Zheng, Yuting, Peiyuan Mei, Mingliang Wang, Qinyue Luo, Hanting Li, Chengyu Ding, Kailu Zhang, et al. 2024. “CT-Based Delta-Radiomics for Predicting Pathological Response to Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Multicenter Study.” BMC Medical Imaging 24 (1): 1–12. doi:10.1186/s12880-024-01503-1.